Clinical Trials Logo

Filter by:
NCT ID: NCT01354184 Completed - Clinical trials for Abdominal Aortic Aneurysm

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

Start date: n/a
Phase: Phase 2
Study type: Interventional

This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.

NCT ID: NCT01363700 Completed - Clinical trials for Allergic Conjunctivitis

Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of the study is to demonstrate safety and efficacy of DE-114 ophthalmic solution compared to its Placebo and Olopatadine hydrochloride 0.1% ophthalmic solution in patients with allergic conjunctivitis.

NCT ID: NCT01363713 Completed - Clinical trials for Allergic Conjunctivitis

A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

Safety and efficacy of DE-114 ophthalmic solution will be evaluated in patients with allergic conjunctivitis, in an open-label, multicenter study.

NCT ID: NCT01374048 Completed - Clinical trials for Idiopathic Normal Pressure Hydrocephalus

Intracranial Pressure Waves Via Lumbar Puncture

Start date: n/a
Phase: N/A
Study type: Observational

Patients are subjected to simultaneous intracranial and lumbar puncture pressure measurements. This study focus on intracranial pulse amplitude. Hypothesis: Intracranial pressure amplitude is reflected by lumbar puncture pressure amplitude.

NCT ID: NCT01384435 Completed - SCD Clinical Trials

A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of KPS-0373 compared to placebo in patients with Spinocerebellar Degeneration (SCD).

NCT ID: NCT01395940 Completed - Endometriosis Clinical Trials

A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.

NCT ID: NCT01411254 Completed - Clinical trials for Diabetic Macular Edema

Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for diabetic macular edema.

NCT ID: NCT01417416 Completed - Clinical trials for Combat Training Stress

Changes in the Permeability of the Blood Brain Barrier and Intestinal Barrier in Humans During Conditions of Stress and Immune Activation: in Vivo Studies

Start date: n/a
Phase: N/A
Study type: Observational

The relevance of BBB and IB permeability changes as a major precipitating cause for cognitive and digestive dysfunction in the military stress setting.

NCT ID: NCT01418417 Completed - Healthy Clinical Trials

Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fasting Conditions

Start date: n/a
Phase: Phase 1
Study type: Interventional

Objective: To compare the single dose bioavailability of Torrent's Pantoprazole Sodium Delayed - Release Tablets 1 × 40 mg and PROTONIX® (Pantoprazole Sodium) Delayed - Release Tablets 1 × 40 mg of Wyeth Pharmaceutical Inc. Dosing periods were separated by a washout period of at least 7 days. Study Design: randomized, open label, two treatment, two period, two sequence, single dose, crossover study in healthy human adult subjects

NCT ID: NCT01418430 Completed - Clinical trials for HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)

Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

Start date: n/a
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the safety of the combination of CHOP plus daclizumab in patients with ATLL previously untreated with anthracycline based chemotherapy.